![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/21 | |
A61K 9/16 | |||
A61K 9/00 | |||
A61K 47/18 |
(11) | Number of the document | 1755650 |
(13) | Kind of document | T |
(96) | European patent application number | 05753131.1 |
Date of filing the European patent application | 2005-05-23 | |
(97) | Date of publication of the European application | 2007-02-28 |
(45) | Date of publication and mention of the grant of the patent | 2008-07-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2005/017914 |
Date | 2005-05-23 |
(87) | Number | WO 2005/115333 |
Date | 2005-12-08 |
(30) | Number | Date | Country code |
574662 P | 2004-05-25 | US | |
650226 P | 2005-02-03 | US |
(72) |
JUNNARKAR, Gunjan, US
DESJARDIN, Michael A., US
LIU, Kui, US
LI, Zengji, US
|
(73) |
Intarcia Therapeutics, Inc.,
24650 Industrial Blvd., Emeryville CA 94545,
US
|
(54) | A BIOMOLECULE-CONTAINING SUSPENSION FORMULATION OF INCREASED STABILITY DELIVERABLE VIA AN IMPLANTABLE DELIVERY DEVICE |
A BIOMOLECULE-CONTAINING SUSPENSION FORMULATION OF INCREASED STABILITY DELIVERABLE VIA AN IMPLANTABLE DELIVERY DEVICE |